Arrhythmias and Clinical EP
COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL

https://doi.org/10.1016/S0735-1097(14)60325-9Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Poster Contributions

Hall C

Saturday, March 29, 2014, 10:00 a.m.-10:45 a.m.

Session Title: Arrhythmias and Clinical EP: State of the Art Anticoagulation for Atrial Fibrillation

Abstract Category: 4. Arrhythmias and Clinical EP: AF/SVT

Presentation Number: 1109-115